相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Regulatory T cell proliferative potential is impaired in human autoimmune disease
Fortunata Carbone et al.
NATURE MEDICINE (2014)
IL-17 and GM-CSF Expression Are Antagonistically Regulated by Human T Helper Cells
Rebecca Noster et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
HLA-DR15-derived self-peptides are involved in increased autologous T cell proliferation in multiple sclerosis
Malte Mohme et al.
BRAIN (2013)
Biased Treg/Th17 balance away from regulatory toward inflammatory phenotype in relapsed multiple sclerosis and its correlation with severity of symptoms
Azam Jamshidian et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
Ashley H. Beecham et al.
NATURE GENETICS (2013)
Intense Inflammation and Nerve Damage in Early Multiple Sclerosis Subsides at Older Age: A Reflection by Cerebrospinal Fluid Biomarkers
Mohsen Khademi et al.
PLOS ONE (2013)
Soluble IL7Rα potentiates IL-7 bioactivity and promotes autoimmunity
Wangko Lundstrom et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis
Adam P. Gregory et al.
NATURE (2012)
Mavrilimumab, a human monoclonal antibody targeting GM-CSF receptor-α, in subjects with rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase I, first-in-human study
Gerd R. Burmester et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors
Erik A. Nelson et al.
BLOOD (2011)
Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility
Nicolas Couturier et al.
BRAIN (2011)
TH17 cytokines in autoimmune neuro-inflammation
Burkhard Becher et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Stephen Sawcer et al.
NATURE (2011)
RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation
Laura Codarri et al.
NATURE IMMUNOLOGY (2011)
The encephalitogenicity of TH17 cells is dependent on IL-1-and IL-23-induced production of the cytokine GM-CSF
Mohamed El-Behi et al.
NATURE IMMUNOLOGY (2011)
Soluble IL-2RA Levels in Multiple Sclerosis Subjects and the Effect of Soluble IL-2RA on Immune Responses
Lisa M. Maier et al.
JOURNAL OF IMMUNOLOGY (2009)
Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource
Calliope A. Dendrou et al.
NATURE GENETICS (2009)
IL2RA Genetic Heterogeneity in Multiple Sclerosis and Type 1 Diabetes Susceptibility and Soluble Interleukin-2 Receptor Production
Lisa M. Maier et al.
PLOS GENETICS (2009)
New insights into the regulation of T cells by γc family cytokines
Yrina Rochman et al.
NATURE REVIEWS IMMUNOLOGY (2009)
The genetics of multiple sclerosis: SNPs to pathways to pathogenesis
Jorge R. Oksenberg et al.
NATURE REVIEWS GENETICS (2008)
How regulatory T cells work
Dario A. A. Vignali et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes
Christopher E. Lowe et al.
NATURE GENETICS (2007)
Risk alleles for multiple sclerosis identified by a genomewide study
David A. Hafler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Daclizumab phase II trial in relapsing and remitting multiple sclerosis - MRI and clinical results
J. W. Rose et al.
NEUROLOGY (2007)
GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis
Eugene D. Ponomarev et al.
JOURNAL OF IMMUNOLOGY (2007)
A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC
Paul I. W. de Bakker et al.
NATURE GENETICS (2006)
Matrix metalloproteinase-9 and autoimmune diseases
Maya Ram et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2006)
Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis
V Viglietta et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β
B Bielekova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Granulocyte macrophage colony-stimulating factor: A new putative therapeutic target in multiple sclerosis
JL McQualter et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
分享论文
